{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:41:31Z","timestamp":1791430891696,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00415-009-5008-7","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T23:57:44Z","timestamp":1235779064000},"page":"750-757","source":"Crossref","is-referenced-by-count":90,"title":["Effects of statins on the progression of cerebral white matter lesion"],"prefix":"10.1007","volume":"256","author":[{"given":"Vincent C. T.","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynnie W. M.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Wing","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak Hon","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Sing","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"issue":"7","key":"5008_CR1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","volume":"1","author":"GC Roman","year":"2002","unstructured":"Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1(7):426\u2013436","journal-title":"Lancet Neurol"},{"issue":"8","key":"5008_CR2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","volume":"27","author":"WT Longstreth Jr","year":"1996","unstructured":"Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA et al (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27(8):1274\u20131282","journal-title":"Stroke"},{"issue":"12","key":"5008_CR3","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.STR.0000103747.58719.59","volume":"34","author":"H Henon","year":"2003","unstructured":"Henon H, Vroylandt P, Durieu I, Pasquier F, Leys D (2003) Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 34(12):2935\u20132940","journal-title":"Stroke"},{"issue":"1","key":"5008_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1212\/WNL.54.1.90","volume":"54","author":"DP Briley","year":"2000","unstructured":"Briley DP, Haroon S, Sergent SM, Thomas S (2000) Does leukoaraiosis predict morbidity and mortality? Neurology 54(1):90\u201394","journal-title":"Neurology"},{"issue":"1","key":"5008_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.167.1.81","volume":"167","author":"D Inzitari","year":"2007","unstructured":"Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H et al (2007) Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 167(1):81\u201388","journal-title":"Arch Intern Med"},{"issue":"1","key":"5008_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.STR.0000149625.99732.69","volume":"36","author":"WT Longstreth Jr","year":"2005","unstructured":"Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C et al (2005) Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36(1):56\u201361","journal-title":"Stroke"},{"issue":"9374","key":"5008_CR7","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(03)13616-1","volume":"361","author":"R Schmidt","year":"2003","unstructured":"Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F (2003) Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 361(9374):2046\u20132048","journal-title":"Lancet"},{"issue":"3","key":"5008_CR8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/01.wnl.0000251302.55202.73","volume":"68","author":"P Sachdev","year":"2007","unstructured":"Sachdev P, Wen W, Chen X, Brodaty H (2007) Progression of white matter hyperintensities in elderly individuals over 3\u00a0years. Neurology 68(3):214\u2013222","journal-title":"Neurology"},{"issue":"9","key":"5008_CR9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/jnnp.2004.055905","volume":"76","author":"E Garde","year":"2005","unstructured":"Garde E, Lykke Mortensen E, Rostrup E, Paulson OB (2005) Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 76(9):1289\u20131291","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5008_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jnnp.2005.070193","volume":"77","author":"DM Heuvel van den","year":"2006","unstructured":"van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL et al (2006) Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 77(2):149\u2013153","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"5008_CR11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/STROKEAHA.107.489112","volume":"38","author":"R Schmidt","year":"2007","unstructured":"Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F (2007) Progression of leukoaraiosis and cognition. Stroke 38(9):2619\u20132625","journal-title":"Stroke"},{"issue":"2","key":"5008_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.STR.0000254712.39076.d6","volume":"38","author":"JV Bowler","year":"2007","unstructured":"Bowler JV, Gorelick PB (2007) Advances in vascular cognitive impairment 2006. Stroke 38(2):241\u2013244","journal-title":"Stroke"},{"issue":"1","key":"5008_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/01.WNL.0000132635.75819.E5","volume":"63","author":"R Schmidt","year":"2004","unstructured":"Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A et al (2004) White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 63(1):139\u2013144","journal-title":"Neurology"},{"issue":"11","key":"5008_CR14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.104.501163","volume":"112","author":"C Dufouil","year":"2005","unstructured":"Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P et al (2005) Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112(11):1644\u20131650","journal-title":"Circulation"},{"key":"5008_CR15","unstructured":"(1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934):1383\u20139"},{"key":"5008_CR16","doi-asserted-by":"crossref","unstructured":"(2002) MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7\u201322","DOI":"10.1016\/S0140-6736(02)09327-3"},{"issue":"19","key":"5008_CR17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","volume":"323","author":"G Brown","year":"1990","unstructured":"Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C et al (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323(19):1289\u20131298","journal-title":"N Engl J Med"},{"issue":"12","key":"5008_CR18","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","volume":"35","author":"P Amarenco","year":"2004","unstructured":"Amarenco P, Labreuche J, Lavallee P, Touboul PJ (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35(12):2902\u20132909","journal-title":"Stroke"},{"issue":"6","key":"5008_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE et al (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355(6):549\u2013559","journal-title":"N Engl J Med"},{"issue":"1","key":"5008_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","volume":"46","author":"M Ii","year":"2007","unstructured":"Ii M, Losordo DW (2007) Statins and the endothelium. Vascul Pharmacol 46(1):1\u20139","journal-title":"Vascul Pharmacol"},{"key":"5008_CR21","unstructured":"Mok V, Lam W, Chen X, Wong A, Ng P, Tsoi T, et al. Statin for asymptomatic middle cerebral artery stenosis: the ROCAS (Regression of Cerebral Artery Stenosis) study. Cerebrovasc Dis (in press)"},{"issue":"3","key":"5008_CR22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1552-6569.2003.tb00187.x","volume":"13","author":"YH Fan","year":"2003","unstructured":"Fan YH, Lam WW, Mok VC, Huang RX, Wong KS (2003) Variability and validity of a simple visual rating scale in grading white matter changes on magnetic resonance imaging. J Neuroimaging 13(3):255\u2013258","journal-title":"J Neuroimaging"},{"issue":"6","key":"5008_CR23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318\u20131322","journal-title":"Stroke"},{"issue":"9","key":"5008_CR24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","volume":"43","author":"F Fazekas","year":"1993","unstructured":"Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43(9):1683\u20131689","journal-title":"Neurology"},{"issue":"10","key":"5008_CR25","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000161844.00797.73","volume":"64","author":"VH ten Dam","year":"2005","unstructured":"ten Dam VH, van den Heuvel DM, van Buchem MA, Westendorp RG, Bollen EL, Ford I et al (2005) Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 64(10):1807\u20131809","journal-title":"Neurology"},{"issue":"9","key":"5008_CR26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/01.wnl.0000182897.18229.ec","volume":"65","author":"C Bernick","year":"2005","unstructured":"Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M et al (2005) Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 65(9):1388\u20131394","journal-title":"Neurology"},{"issue":"3","key":"5008_CR27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.STR.0000202585.26325.74","volume":"37","author":"EC Straaten van","year":"2006","unstructured":"van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, Pantoni L et al (2006) Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37(3):836\u2013840","journal-title":"Stroke"},{"issue":"12","key":"5008_CR28","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/hs1201.099663","volume":"32","author":"P Sterzer","year":"2001","unstructured":"Sterzer P, Meintzschel F, Rosler A, Lanfermann H, Steinmetz H, Sitzer M (2001) Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke 32(12):2817\u20132820","journal-title":"Stroke"},{"issue":"5","key":"5008_CR29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","volume":"95","author":"G O\u2019Driscoll","year":"1997","unstructured":"O\u2019Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1\u00a0month. Circulation 95(5):1126\u20131131","journal-title":"Circulation"},{"issue":"7","key":"5008_CR30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","volume":"83","author":"M Essig","year":"1998","unstructured":"Essig M, Nguyen G, Prie D, Escoubet B, Sraer JD, Friedlander G (1998) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 83(7):683\u2013690","journal-title":"Circ Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5008-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5008-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:08:23Z","timestamp":1559070503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5008-7"}},"subtitle":["Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study"],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5008-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}